Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $20.10B as of Sunday, July 26, 2026.
ENTERPRISE VALUE (EV)
$20.10B
Moderna, Inc.
Market Cap
$21.45B
Enterprise Value (EV)
$20.10B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Moderna, Inc. (MRNA) | $21.45B | $20.10B |
| STERIS plc (STE)vs › | $20.86B | $22.51B |
| United Therapeutics Corporation (UTHR)vs › | $22.43B | $21.36B |
| BioNTech SE (BNTX)vs › | $22.59B | $11.45B |
| Viatris Inc. (VTRS)vs › | $20.08B | $32.62B |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.10B | $22.97B |
| Incyte Corporation (INCY)vs › | $23.51B | $20.08B |
| Labcorp Holdings Inc. (LH)vs › | $24.34B | $30.59B |
| Waters Corporation (WAT)vs › | $24.42B | $29.53B |
| Quest Diagnostics Incorporated (DGX)vs › | $25.15B | $30.91B |
Market Cap
$21.45B
Total Debt
$1.24B
Cash
$2.60B
Enterprise Value
$20.10B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
